Well this announcement has me confused?So Alstrm Syndrome, a very rare disease in the UK and IPF are the new priorities? Not a mention of 4050 and type 2 diabetes anywhere in the statement. That was the reason I got in the stock was the huge potential they were hyping 4050 and type 2 diabetes. Now that’s where I thought the huge market would be. Are they not telling us that this potential cure is done? If anyone has some info on where PLI stands on their tests with diabetes can you please share. I’ve read this latest news release several times and I’m more confused than ever.